R21/Matrix-M vaccine offers significant protection against malaria in African children
1. The R21/Matrix-M vaccine had a high 12-month efficacy across seasonal and standard sites. 2. The reduction in malarial infection rates was 4 times greater at seasonal sites compared to standard sites. Evidence Rating Level: 1 (Excellent) Study Rundown: The...